Caribou Biosciences (CRBU) Net Margin (2020 - 2025)
Historic Net Margin for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to 1337.58%.
- Caribou Biosciences' Net Margin rose 5516500.0% to 1337.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 1708.08%, marking a year-over-year decrease of 2685800.0%. This contributed to the annual value of 1491.95% for FY2024, which is 11958900.0% down from last year.
- Caribou Biosciences' Net Margin amounted to 1337.58% in Q3 2025, which was up 5516500.0% from 1783.95% recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Net Margin registered a high of 61.84% during Q3 2023, and its lowest value of 1893.87% during Q1 2024.
- Moreover, its 5-year median value for Net Margin was 888.52% (2023), whereas its average is 1098.7%.
- Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 7720900bps in 2021, then tumbled by -18273900bps in 2024.
- Quarter analysis of 5 years shows Caribou Biosciences' Net Margin stood at 722.12% in 2021, then fell by -15bps to 828.22% in 2022, then decreased by -27bps to 1052.33% in 2023, then crashed by -78bps to 1871.69% in 2024, then increased by 29bps to 1337.58% in 2025.
- Its last three reported values are 1337.58% in Q3 2025, 1783.95% for Q2 2025, and 1823.76% during Q1 2025.